Who is sponsoring NCT03219944?

NCT03219944 is sponsored by Cairo University.

What drugs are being tested in NCT03219944?

Interventions in NCT03219944: Platelet Rich Fibrin, sub epithelial connective tissue graft.

Is NCT03219944 still recruiting?

NCT03219944 is currently status unknown. Last updated 19 July 2017.

Last reviewed 2017-07-19 · How we verify

NCT03219944

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Evaluation of Platelet Rich Fibrin Versus Subepithelial Connective Tissue Graft for Soft Tissue Augmentation

Status unknown NA Last updated 19 July 2017

What this trial tests

NA trial testing Platelet Rich Fibrin in Patients With at Least Single Missing Anterior Tooth in 16 participants. Status unknown.

Timeline

15 August 2017

Primary endpoint
1 January 2018

1 January 2018

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	16
Start date	15 August 2017
Primary completion	1 January 2018
Estimated completion	1 January 2018
Sites	1 location across Egypt

Drugs / interventions tested

Platelet Rich Fibrin — full drug profile →
sub epithelial connective tissue graft

Conditions studied

Patients With at Least Single Missing Anterior Tooth — all drugs for Patients With at Least Single Missing Anterior Tooth →
Thin Gingival Biotype — all drugs for Thin Gingival Biotype →

Sponsor

Cairo University

Who can join

Adults 20 to 60, any sex, with Patients With at Least Single Missing Anterior Tooth or Thin Gingival Biotype. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Soft tissue biotype is a critical factor for success of implant in the esthetic zone . Different soft tissue augmentation techniques have been employed to increase soft tissue thickness such as: autogenous grafts, allografts, xenografts and living cellular construct (LCC). Studies showed that, allografts and xenografts were inferior when compared with autogenous graft . However, few studies were conducted to evaluate the efficacy of soft tissue augmentation with platelet rich fibrin in order to overcome the patient morbidity with SCTG.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Platelet Rich Fibrin

Trials testing the same drug.

NCT06037070 — Impact of Biological Factors on Dental Implant · NA · unknown
NCT06768424 — Comparison of MIST With PRF and GBT With PRF in the Treatment of Intrabony Periodontal Defect. A Prospective RCT · NA · active not recruiting
NCT07078006 — Injectable Platelet Rich Fibrin Versus Platelet Rich Plasma Injection in Degenerative Temporomandibular Joint · NA · completed
NCT06173492 — Platelet Rich Fibrin (PRF) in Socket Preservation Technique · NA · unknown
NCT05517733 — ASSESSMENT OF SOFT TISSUE HEALING OVER IMMEDIATELY PLACED IMPLANT SEALED WITH PLATELETS RICH FIBRIN (PRF) VERSUS DIODE L · NA · completed

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03219944 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 19 July 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03219944.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing